Galmed Pharmaceuticals Ltd.

GLMDNASDAQUSD
0.54 USD
0.01 (0.93%)🟢LIVE (AS OF 03:35 PM EDT)
🟢Market: OPEN
Open?$0.52
High?$0.56
Low?$0.52
Prev. Close?$0.54
Volume?32.9K
Avg. Volume?N/A
VWAP?$0.52
Bid / Ask
Bid?$0.45 × 100
Ask?$0.63 × 100
Spread?$0.18
Midpoint?$0.54
Valuation & Ratios
Market Cap?3.6M
Shares Out?6.6M
Float?6.3M
Float %?96.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
Employees
6
Market Cap
3.6M
Industry
N/A
Listed
2014-03-13